Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03475953 |
| Title | A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Institut Bergonie |
| Indications |
differentiated thyroid gland carcinoma lung non-squamous non-small cell carcinoma |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA |
CKB BOOST